The safety and efficacy of adjusted-dose enoxaparin (clexane) in pregnant patients with increased risk for venous thrombo-embolic disease: a retrospective analysis of clinical and laboratory data

Simple item page
dc.contributor.authorBaily, Jenique
dc.date.accessioned2019-09-12T13:48:13Z
dc.date.available2019-09-12T13:48:13Z
dc.date.issued2018
dc.description.librarianMT 2019en_ZA
dc.format.extentOnline resource (20 leaves)
dc.identifier.citationBailly, Jenique (2019) The safety and efficacy of adjusted-dose enoxaparin(Clexane®) in pregnant patients with increased risk for venous thrombo-embolic disease :a retrospective analysis of clinical and laboratory data, University of the Witwatersrand, Johannesburg, <http://hdl.handle.net/10539/28102>
dc.identifier.urihttps://hdl.handle.net/10539/28102
dc.language.isoenen_ZA
dc.subject.meshEnoxaparin
dc.subject.meshHeart Transplantation
dc.titleThe safety and efficacy of adjusted-dose enoxaparin (clexane) in pregnant patients with increased risk for venous thrombo-embolic disease: a retrospective analysis of clinical and laboratory dataen_ZA
dc.typeThesisen_ZA

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
MMed J Bailly.pdf
Size:
2.33 MB
Format:
Adobe Portable Document Format
Description:
Download

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

ETD Collection